Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
4 "Cardiometabolic risk"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Article
Thyroid
Prevalence of Subclinical Hypothyroidism in a Non-Diabetic Young Female Population and Its Impact on Diabetes and Cardiometabolic Risk
Nawoda Hewage, Udaya Wijesekara, Rasika Perera
Endocrinol Metab. 2024;39(6):864-876.   Published online November 5, 2024
DOI: https://doi.org/10.3803/EnM.2024.2015
  • 1,642 View
  • 77 Download
AbstractAbstract PDFPubReader   ePub   
Background
We evaluated the influence of subclinical hypothyroidism (SCH) on insulin resistance (IR), cardiometabolic risk, and obesity in childbearing-age women without diabetes.
Methods
This cross-sectional investigation included 282 women, aged 18 to 35 years, from rural and suburban Sri Lanka. Anthropometric and biochemical parameters, including IR and lipid/thyroid profiles, were recorded. Data were compared between SCH and euthyroidism (EU) for controls (normal weight) and cases (overweight/obese).
Results
The overall rates of SCH, EU, IR, and metabolic syndrome (MetS) were 40.42%, 59.57%, 73.40%, and 24.46%, respectively. Both controls and cases included individuals with SCH; overall, 168 participants (59.57%) had EU, while 114 (40.42%) exhibited SCH. IR was significantly associated with SCH in both weight groups (P<0.05). Among those with SCH, the odds ratios (ORs) for IR were >2 (95% confidence interval [CI], 0.45 to 3.87) in controls and >6 (95% CI, 3.52 to 8.41) in cases. Similarly, the ORs for MetS were >1 (95% CI, 0.38 to 4.16) in controls and >11 (95% CI, 8.73 to 15.01) in cases. Dyslipidemia and hypertriglyceridemia were significantly more prevalent in the SCH group (P<0.05). Women with SCH exhibited higher mean values for all obesity indices compared to their EU counterparts, surpassing normal thresholds (P<0.05). Among obesity measures, visceral adiposity index (VAI) demonstrated the highest area under the curve and sensitivity for assessing SCH and cardiovascular disease (CVD) risk.
Conclusion
SCH must be identified and managed in young women to help prevent diabetes and cardiometabolic disorders. VAI may aid in precisely detecting SCH and CVD.
Close layer
Review Article
Obesity and Metabolism
An Update on Contraception in Polycystic Ovary Syndrome
Seda Hanife Oguz, Bulent Okan Yildiz
Endocrinol Metab. 2021;36(2):296-311.   Published online April 15, 2021
DOI: https://doi.org/10.3803/EnM.2021.958
  • 24,019 View
  • 1,045 Download
  • 34 Web of Science
  • 38 Crossref
AbstractAbstract PDFPubReader   ePub   
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in reproductive-aged women, characterized by hyperandrogenism, oligo/anovulation, and polycystic ovarian morphology. Combined oral contraceptives (COCs), along with lifestyle modifications, represent the first-line medical treatment for the long-term management of PCOS. Containing low doses of estrogen and different types of progestin, COCs restore menstrual cyclicity, improve hyperandrogenism, and provide additional benefits such as reducing the risk of endometrial cancer. However, potential cardiometabolic risk associated with these agents has been a concern. COCs increase the risk of venous thromboembolism (VTE), related both to the dose of estrogen and the type of progestin involved. Arterial thrombotic events related to COC use occur much less frequently, and usually not a concern for young patients. All patients diagnosed with PCOS should be carefully evaluated for cardiometabolic risk factors at baseline, before initiating a COC. Age, smoking, obesity, glucose intolerance or diabetes, hypertension, dyslipidemia, thrombophilia, and family history of VTE should be recorded. Patients should be re-assessed at consecutive visits, more closely if any baseline cardiometabolic risk factor is present. Individual risk assessment is the key in order to avoid unfavorable outcomes related to COC use in women with PCOS.

Citations

Citations to this article as recorded by  
  • Impact of short‐term ketogenic diet on sex hormones and glucose‐lipid metabolism in overweight or obese patients with polycystic ovary syndrome
    Meng Li, Lisong Zhang, Xiaoyu Li, Yanzhong Zhao
    Journal of Obstetrics and Gynaecology Research.2025;[Epub]     CrossRef
  • Exploring the efficacy of Wenshentiaojing decoction in PCOS: Network pharmacology and mouse model insights
    Mingming Wang, Jing Huang, Yue Shi, Richard Mprah, Huanhuan Ding, Shanshan Zhang, Cui Li
    Bioorganic Chemistry.2025; 154: 108089.     CrossRef
  • Targeting UGT2B15 and NR1H4 interaction: a novel therapeutic strategy for polycystic ovary syndrome using naftopidil enantiomers
    Xiufen Zheng, Zikai Chen, Miao Liang, Liting Zhou, Miaoru Wang, Silin Zhang, Shuyun Zhang, Lei Ma, Wei Yi, Xiawen Liu
    Journal of Ovarian Research.2025;[Epub]     CrossRef
  • Postpartum hormonal contraceptive use in Denmark during 1997–2021
    Søren Vinther Larsen, Anders Pretzmann Mikkelsen, Kathrine Bang Madsen, Xiaoqin Liu, Trine Munk-Olsen, Vibe Gedso Frokjaer, Øjvind Lidegaard
    Sexual & Reproductive Healthcare.2025; 43: 101075.     CrossRef
  • Association of Polycystic Ovary Syndrome with Clinical, Physical, and Reproductive Factors: A Data-Driven Analysis
    Ismat Ara Begum, A. S. M. Sanwar Hosen, Deepak Ghimire, Mi Jin Park
    Diagnostics.2025; 15(6): 711.     CrossRef
  • Association of Different Formulation with Oral Contraceptive Agents in Lipid and Carbohydrates Metabolism in Women
    Syeda Masooma Hussain, Sikandar Ali Khan, Somaya Noor, Najma Fida, Syed Muhammad Sajid Ali Bukhari, Jahangir Zeb
    Pakistan Journal of Health Sciences.2025; : 66.     CrossRef
  • Development of a Long-Acting Follicle-Stimulating Hormone Using Serum Albumin Fab-Associated Technology for Female Infertility
    Daham Kim, Yoon Hee Cho, Min Jeong Kang, So Jeong Lee, Soohyun Lee, Bo Hyon Yun, Hyunjin Chi, Jeongsuk An, Kyungsun Lee, Jaekyu Han, Susan Chi, Moo Young Song, Sang-Hoon Cha, Eun Jig Lee
    Endocrinology and Metabolism.2025; 40(1): 146.     CrossRef
  • Recurrent Giant Ovarian Cysts in Biological Sisters: 2 Case Reports and Literature Review—Giant Ovarian Cysts in 2 Sisters
    Shuaibin Liu, Qianru Zeng, Lina Hu, Biao Zeng, Yi Wu, Chenxi Wang, Min Zhou, Xiaoling Gan
    Healthcare.2025; 13(6): 656.     CrossRef
  • ‘Ovariostasis’ as the main preventive and therapeutic strategy for gynecological pathologies in women of reproductive age
    Antonio La Marca, Chiara Selmi
    Human Reproduction.2025; 40(6): 983.     CrossRef
  • Association of Polycystic Ovarian Syndrome Features and Metabolic Syndrome Among Reproductive-Aged Women in the United States
    Deepali K. Ernest, Asha Collier, Aparajita Chandrasekhar, Luyu Xie, Shaghayegh Darraji, Jenil Patel, Jaime P. Almandoz, Sarah E. Messiah
    Women's Health Reports.2025; 6(1): 431.     CrossRef
  • Extracellular fluid miRNAs in PCOS
    Saba Hadi, Seyed Hossein Khoshraftar, Amir Hossein Kiani Darabi, Anahita Soleimani, Hamid Reza Nejabati
    Clinica Chimica Acta.2025; 576: 120404.     CrossRef
  • Impact of oral contraceptive use on muscle mass and strength in women with PCOS
    Seren Aksun, Levend Karaçoban, Ilkay Idilman, Bulent O. Yildiz
    Endocrine.2025;[Epub]     CrossRef
  • Recognizing the Role of Insulin Resistance in Polycystic Ovary Syndrome: A Paradigm Shift from a Glucose-Centric Approach to an Insulin-Centric Model
    Jim Parker, Lara Briden, Felice L. Gersh
    Journal of Clinical Medicine.2025; 14(12): 4021.     CrossRef
  • Clinical management of androgen excess and defect in women
    Elena Rosato, Francesca Sciarra, Marianna Minnetti, Anisa Degjoni, Mary Anna Venneri
    Expert Review of Endocrinology & Metabolism.2024; 19(1): 21.     CrossRef
  • Il rischio tromboembolico nella sindrome dell’ovaio policistico
    Davide Ceccato, Francesca Dassie, Pietro Maffei, Roberto Mioni
    L'Endocrinologo.2024; 25(2): 151.     CrossRef
  • Systematic exploration of network pharmacology, in silico modeling and pharmacokinetic profiling for vitamin E in polycystic ovarian syndrome
    Rukaiah Fatma Begum, Sumithra Mohan
    Future Science OA.2024;[Epub]     CrossRef
  • The ameliorating effects of apigenin and chrysin alone and in combination on polycystic ovary syndrome induced by dehydroepiandrosterone in rats
    Buket Berk, Nevin İlhan, Solmaz Susam, Fatma Tedik, Nalan Kaya Tektemur
    Marmara Medical Journal.2024; 37(2): 198.     CrossRef
  • Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment
    Ting Zhao, Xiao Xiao, Lingchuan Li, Jing Zhu, Wenli He, Qiong Zhang, Jiaqi Wu, Xiaomei Wu, Tao Yuan
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Association Between Intrauterine System Hormone Dosage and Depression Risk
    Søren Vinther Larsen, Anders Pretzmann Mikkelsen, Brice Ozenne, Trine Munk-Olsen, Øjvind Lidegaard, Vibe Gedso Frokjaer
    American Journal of Psychiatry.2024; 181(9): 834.     CrossRef
  • Combined oral contraceptive use and obesity in women with polycystic ovary syndrome. A meta-analysis of randomized clinical trials
    Sebastião Freitas de Medeiros, José Maria Soares Junior, Matheus Antonio Souto de Medeiros, Ana Karine Lin Winck Yamamoto, Cindy Lin Winck de Medeiros, Anna Bethany da Silva Carvalho, Márcia Marly Winck Yamamoto, Edmund Chada Baracat
    Archives of Gynecology and Obstetrics.2024; 310(4): 2223.     CrossRef
  • Dietary supplements in polycystic ovary syndrome–current evidence
    Ya Han, Ye Hou, Qimao Han, Xingxing Yuan, Lu Chen
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Oxidative Stress in Polycystic Ovary Syndrome: Impact of Combined Oral Contraceptives
    Nicolás Santander, Esteban G. Figueroa, Alejandro González-Candia, Manuel Maliqueo, Bárbara Echiburú, Nicolás Crisosto, Francisca Salas-Pérez
    Antioxidants.2024; 13(10): 1168.     CrossRef
  • miRNAs in ovarian disorders: Small but strong cast
    Parsa Tafazoli, Hanieh Motahari Rad, Mehri Mashayekhi, Seyedeh Fatemeh Siadat, Rouhollah Fathi
    Pathology - Research and Practice.2024; 264: 155709.     CrossRef
  • Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
    Chandrani Dutta, Srivarshini Maddukuri
    Cureus.2024;[Epub]     CrossRef
  • Review of current therapeutic approaches for polycystic ovary syndrome
    Teodora Mitrovic, Artur Bjelica, Djordje Petrovic, Dragan Stajic
    Medicinski pregled.2024; 77(9-12): 309.     CrossRef
  • Current and emerging drug treatment strategies for polycystic ovary syndrome
    Nafiye Helvaci, Bulent Okan Yildiz
    Expert Opinion on Pharmacotherapy.2023; 24(1): 105.     CrossRef
  • Weighted Gene Co-Expression Network Analysis (WGCNA) Discovered Novel Long Non-Coding RNAs for Polycystic Ovary Syndrome
    Roozbeh Heidarzadehpilehrood, Maryam Pirhoushiaran, Malina Binti Osman, Habibah Abdul Hamid, King-Hwa Ling
    Biomedicines.2023; 11(2): 518.     CrossRef
  • The mechanism of Leonuri Herba in improving polycystic ovary syndrome was analyzed based on network pharmacology and molecular docking
    Mali Wu, Hua Liu, Jie Zhang, Fangfang Dai, Yiping Gong, Yanxiang Cheng
    Journal of Pharmacy & Pharmaceutical Sciences.2023;[Epub]     CrossRef
  • Evaluation of the efficacy of an antioxidant combination for the modulation of metabolic, endocrine, and clinical parameters in patients with polycystic ovary syndrome
    Carmen Pingarrón Santofímia, Silvia Poyo Torcal, Helena López Verdú, Alexandra Henríquez Linares, Virginia Calvente Aguilar, Pablo Terol Sánchez, María Sol Martínez García, Pilar Lafuente González
    Gynecological Endocrinology.2023;[Epub]     CrossRef
  • Contemporary Management of the Patient with Polycystic Ovary Syndrome
    Nicolás Omar Francone, Tia Ramirez, Christina E. Boots
    Obstetrics and Gynecology Clinics of North America.2023; 50(4): 695.     CrossRef
  • Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care
    Beate C. Sydora, Michaelann S. Wilke, Maggie McPherson, Sarah Chambers, Mahua Ghosh, Donna F. Vine
    BMC Women's Health.2023;[Epub]     CrossRef
  • Effect of Berberine Phytosome on reproductive, dermatologic, and metabolic characteristics in women with polycystic ovary syndrome: a controlled, randomized, multi-centric, open-label clinical trial
    Francesco Di Pierro, Ruqqia Sultana, Amna Zia Eusaph, Saida Abrar, Mahroo Bugti, Fauzia Afridi, Umer Farooq, Somia Iqtadar, Fareeha Ghauri, Syeda Makhduma, Shazia Nourin, Ayesha Kanwal, Aasiya Bano, Ali Akbar Bugti, Shah Mureed, Ayesha Ghazal, Romana Irsh
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Investigation of taste function and eating behavior in women with polycystic ovary syndrome
    Sila Cetik, Aylin Acikgoz, Bulent Okan Yildiz
    Appetite.2022; 168: 105776.     CrossRef
  • microRNAs and long non‐coding RNAs as biomarkers for polycystic ovary syndrome
    Mona Tamaddon, Mostafa Azimzadeh, Seyed Mohammad Tavangar
    Journal of Cellular and Molecular Medicine.2022; 26(3): 654.     CrossRef
  • Effect of orlistat during individualized comprehensive life-style intervention on visceral fat in overweight or obese PCOS patients
    Min Min, Xiangyan Ruan, Husheng Wang, Jiaojiao Cheng, Suiyu Luo, Zhongting Xu, Meng Li, Alfred Otto Mueck
    Gynecological Endocrinology.2022; 38(8): 676.     CrossRef
  • Effect of metformin and exenatide on pregnancy rate and pregnancy outcomes in overweight or obese infertility PCOS women: long-term follow-up of an RCT
    Renyuan Li, Tingting Mai, Siyuan Zheng, Ying Zhang
    Archives of Gynecology and Obstetrics.2022; 306(5): 1711.     CrossRef
  • Oral contraceptives and stroke: Foes or friends
    Varun Reddy, Megan Wurtz, Shahil H. Patel, Micheline McCarthy, Ami P. Raval
    Frontiers in Neuroendocrinology.2022; 67: 101016.     CrossRef
  • Clinical profiling of polycystic ovary syndrome patients in Kashmir population
    Ahila Ashraf, Rajesh Singh, Shahnawaz Mir
    Matrix Science Pharma.2022; 6(1): 23.     CrossRef
Close layer
Original Articles
Obesity and Metabolism
Associations between Dietary Acid-Base Load and Cardiometabolic Risk Factors in Adults: The Tehran Lipid and Glucose Study
Zahra Bahadoran, Parvin Mirmiran, Hadise Khosravi, Fereidoun Azizi
Endocrinol Metab. 2015;30(2):201-207.   Published online June 30, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.2.201
  • 5,019 View
  • 35 Download
  • 39 Web of Science
  • 39 Crossref
AbstractAbstract PDFPubReader   
Background

In this study we investigated the associations of dietary acid-base load, identified by potential renal acid load (PRAL) and protein to potassium (Pro:K) ratio, with cardiometabolic risk factors in Tehranian adults.

Methods

A cross-sectional study was conducted within the framework of the fourth phase of the Tehran Lipid and Glucose Study (2009 to 2011) on 5,620 men and women aged 19 to 70 years. Dietary data were collected by a trained dietitian using a validated, 147-food item, semi-quantitative food frequency questionnaire, and dietary PRAL and Pro:K ratio were calculated. Multiple linear regression models with adjustment for potential confounding variables were used to evaluate the associations of dietary acid-base load with anthropometric measures, blood pressure, serum triglycerides, high density lipoprotein cholesterol (HDL-C), serum creatinine, and fasting blood glucose.

Results

The mean±SD age of the participants was 39.8±12.8 years and 54% of participants were women. Mean±SD PRAL was -22.0±29.1; mean PRAL was -15.6 in men and -26.8 in women. Dietary PRAL was associated with weight (β=0.098, P<0.001), waist circumference (β=0.062, P<0.01), serum triglycerides (β=0.143, P<0.01), HDL-C (β=-0.11, P<0.01), diastolic blood pressure (β=0.062, P<0.01), and serum creatinine (β=0.142, P<0.001). Pro:K ratio was associated with weight (β=0.055, P<0.001), waist circumference (β=0.04, P<0.01), serum HDL-C (β=-0.06, P<0.01), serum triglycerides (β=0.03, P<0.05), diastolic blood pressure (β=0.026, P<0.05), and serum creatinine (β=0.07, P<0.01).

Conclusion

A more acidic dietary acid-base load may be a risk factor for the development of metabolic disorders.

Citations

Citations to this article as recorded by  
  • Relationship between TyG-BMI index and glycemic index with diet quality, anthropometric indices, and blood pressure in patients with metabolic syndrome
    Paria Moulavi, Afsane Ahmadi, Seyed Jalil Masoumi, Morteza Zare, Mahdi Honardoust, Rahil Ranjbar
    Medicine.2025; 104(3): e41276.     CrossRef
  • Dietary Acid Load and Human Health: A Systematic Review and Meta-analysis of Observational Studies
    Maryam Abbastabar, Zahra Mohammadi-Pirouz, Shabnam Omidvar, Afsaneh Bakhtiari, Francesca L Crowe, Mahdi Sepidarkish
    Nutrition Reviews.2025;[Epub]     CrossRef
  • The association between dietary acid load and indices of insulin resistance
    Niloufar Abdollahpour, Najmeh Seifi, Alireza Abbas Abad Arabi, Negar Sadat Sanei Shahri, Ali Ferasati, Hanieh Keikhay Moghadam, Habibollah Esmaily, Gordon A. Ferns, Majid Ghayour-Mobarhan
    Scientific Reports.2025;[Epub]     CrossRef
  • Dietary Acid Load and the Risk of All-Cause Mortality: A Systematic Review and Meta-Analysis of Observational Studies
    Fatemeh Hajizadeh-Sharafabad, Sara Shojaei-Zarghani, Elham Sharifi-Zahabi, Nastaran Najafi, Mohammad Reza Pashaei
    Nutrition Reviews.2025;[Epub]     CrossRef
  • A high dietary acid load can potentially exacerbate cardiometabolic risk factors: An updated systematic review and meta-analysis of observational studies
    Shamim Dolati, Soha Razmjouei, Mohammad Alizadeh, Amir Hossein Faghfouri, Amir Hossein Moridpour
    Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(3): 569.     CrossRef
  • High dietary acid load predicts severity of autoimmune skin disease: a cross-sectional study
    Maryam Fallah, Banafsheh Jafari Azad, Anahita Najafi, Zahra Esmaeily, Kamran Balighi, Maryam Daneshpazhooh, Soraiya Ebrahimpour-Koujan
    Scientific Reports.2024;[Epub]     CrossRef
  • Dietary acid load and cardiovascular diseases
    Nursel Sahın, Ugur Gunsen
    Critical Reviews in Food Science and Nutrition.2023; 63(28): 9033.     CrossRef
  • Health Inequities in the USA: a Role for Dietary Acid Load? Results from the National Health and Nutrition Examination Surveys
    Maximilian Andreas Storz
    Journal of Racial and Ethnic Health Disparities.2023; 10(6): 2851.     CrossRef
  • Dietary acid load is associated with waist circumference in university students with low adherence to the Mediterranean diet: The potential role of ultra-processed foods
    Paraskevi Detopoulou, Vassilios Dedes, Ioanna Pylarinou, Dimitra Syka, Konstantinos Tzirogiannis, Georgios I. Panoutsopoulos
    Clinical Nutrition ESPEN.2023; 56: 43.     CrossRef
  • Dietary acid load and its interaction with CETP TaqB1 polymorphisms on lipid profile among patients with Type 2 diabetes mellitus
    Faezeh Abaj, Zahra Esmaeily, Zeinab Naeini, Ehsan Alvandi, Masoumeh Rafiee, Fariba Koohdani
    BMC Endocrine Disorders.2023;[Epub]     CrossRef
  • A Nutrigenetic Approach to Investigate ApoB EcoR1 Polymorphism-Dietary Acid Load Interactions on Lipid and Anthropometric-Related Outcomes in Adults with Dyslipidemic Type 2 Diabetes
    Zeinab Naeini, Faezeh Abaj, Zahra Esmaeily, Ehsan Alvandi, Masoumeh Rafiee, Fariba Koohdani
    Lifestyle Genomics.2023; 16(1): 61.     CrossRef
  • Interaction of dietary acid load and general and central obesity with muscle strength and skeletal muscle mass
    Saba Mohammadpour, Parivash Ghorbaninejad, Mahshid Shahavandi, Sakineh Shab-Bidar
    Clinical Nutrition ESPEN.2022; 48: 361.     CrossRef
  • Dietary acid load modifies the effects of ApoA2–265 T > C polymorphism on lipid profile and serum leptin and ghrelin levels among type 2 diabetic patients
    Faezeh Abaj, Zahra Esmaeily, Zeinab Naeini, Masoumeh Rafiee, Fariba Koohdani
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • The association between dietary acid load and adiposity measures among children and adolescents
    Nasim Sorraya, Arman Arab, Shokoofeh Talebi
    BMC Pediatrics.2022;[Epub]     CrossRef
  • Metabolic status is not related to dietary acid load in polycystic ovary syndrome
    Tülay OMMA, Fatmanur Hümeyra ZENGİN, Süheyla AYDOĞMUŞ, Cavit ÇULHA
    Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi.2022; 55(2): 111.     CrossRef
  • EVALUATION OF THE RELATIONSHİP BETWEEN QUALITY OF LIFE AND DIETARY ACID LOAD IN OBESE WOMEN
    Nurefşan KONYALIGİL, Betül ÇİÇEK, Tuba TEKİN, Meltem ÜNLÜSAVURAN SÖNMEZ
    Karya Journal of Health Science.2022; 3(2): 145.     CrossRef
  • Carbohydrate Intake and Its Association With Dietary Acid Load in U.S. Adults: Results From a Cross-Sectional Study
    Maximilian A. Storz, Alvaro L. Ronco
    American Journal of Lifestyle Medicine.2022; : 155982762211332.     CrossRef
  • The association between dietary acid load and body composition in physical education students aged 18–25 years
    Maryam Mansordehghan, Elnaz Daneshzad, Vahid Basirat, Bahram Pourghassem Gargari, Tohid Rouzitalab
    Journal of Health, Population and Nutrition.2022;[Epub]     CrossRef
  • Association of dietary acid load with anthropometric indices in children and adolescents
    Zahra Aslani, Maryam Bahreynian, Nazli Namazi, Nitin Shivappa, James R. Hébert, Hamid Asayesh, Mohammad Esmaeil Motlagh, Mohammad Ali Pourmirzaei, Amir Kasaeian, Armita Mahdavi-Gorabi, Mostafa Qorbani, Roya Kelishadi
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.2021; 26(2): 555.     CrossRef
  • Dietary acid load, kidney function and risk of chronic kidney disease: A systematic review and meta-analysis of observational studies
    Manije Darooghegi Mofrad, Elnaz Daneshzad, Leila Azadbakht
    International Journal for Vitamin and Nutrition Research.2021; 91(3-4): 343.     CrossRef
  • The association between dietary acid load with cardiometabolic risk factors and inflammatory markers amongst elderly men: A cross‐sectional study
    Alireza Jafari, Mahtab Ghanbari, Hossein Shahinfar, Nick Bellissimo, Leila Azadbakht
    International Journal of Clinical Practice.2021;[Epub]     CrossRef
  • Dietary Acid Load and Its Interaction with IGF1 (rs35767 and rs7136446) and IL6 (rs1800796) Polymorphisms on Metabolic Traits among Postmenopausal Women
    Sook Yee Lim, Yoke Mun Chan, Vasudevan Ramachandran, Zalilah Mohd Shariff, Yit Siew Chin, Manohar Arumugam
    Nutrients.2021; 13(7): 2161.     CrossRef
  • Associations between dietary acid load and obesity among Iranian women
    Somaye Fatahi, Mostafa Qorbani, Pamela J. Surkan, Leila Azadbakht
    Journal of Cardiovascular and Thoracic Research.2021; 13(4): 285.     CrossRef
  • Higher dietary acid load is not associated with risk of breast cancer in Iranian women
    Maryam Safabakhsh, Hossein Imani, Mehdi Yaseri, Ramesh Omranipour, Sakineh Shab‐Bidar
    Cancer Reports.2020;[Epub]     CrossRef
  • Dietary acid load, blood pressure, fasting blood sugar and biomarkers of insulin resistance among adults: Findings from an updated systematic review and meta‐analysis
    Parvin Dehghan, Mahdieh Abbasalizad Farhangi
    International Journal of Clinical Practice.2020;[Epub]     CrossRef
  • Ameliorating Chronic Kidney Disease Using a Whole Food Plant-Based Diet
    Kathleen E. Adair, Rodney G. Bowden
    Nutrients.2020; 12(4): 1007.     CrossRef
  • Positive association between dietary acid load and future insulin resistance risk: findings from the Korean Genome and Epidemiology Study
    Kyung Won Lee, Dayeon Shin
    Nutrition Journal.2020;[Epub]     CrossRef
  • Dietary Acid Load and Cardiometabolic Risk Factors—A Narrative Review
    Joanna Ostrowska, Justyna Janiszewska, Dorota Szostak-Węgierek
    Nutrients.2020; 12(11): 3419.     CrossRef
  • Dietary acid load and cardiometabolic risk factors: a systematic review and meta-analysis of observational studies
    Elnaz Daneshzad, Fahimeh Haghighatdoost, Leila Azadbakht
    Public Health Nutrition.2019; 22(15): 2823.     CrossRef
  • The Associations of Dietary Acid Load with Insulin Resistance and Type 2 Diabetes: A Systematic Review of Existing Human Studies
    Hadi Emamat, Hadith Tangestani, Zahra Bahadoran, Sajjad Khalili-Moghadam, Parvin Mirmiran
    Recent Patents on Food, Nutrition & Agriculture.2019; 10(1): 27.     CrossRef
  • Association of dietary acid load with cardiovascular risk factors and the prevalence of metabolic syndrome in Iranian women: A cross-sectional study
    Hadis Mozaffari, Nazli Namazi, Bagher Larijani, Nick Bellissimo, Leila Azadbakht
    Nutrition.2019; 67-68: 110570.     CrossRef
  • Higher dietary acid load potentially increases serum triglyceride and obesity prevalence in adults: An updated systematic review and meta-analysis
    Mahdieh Abbasalizad Farhangi, Leila Nikniaz, Zeinab Nikniaz, Raffaele Serra
    PLOS ONE.2019; 14(5): e0216547.     CrossRef
  • Dietary acid load significantly predicts 10-years survival in patients underwent coronary artery bypass grafting (CABG) surgery
    Mahdieh Abbasalizad Farhangi, Mahdi Vajdi, Mahdi Najafi, Raffaele Serra
    PLOS ONE.2019; 14(10): e0223830.     CrossRef
  • Higher dietary acid load is associated with higher likelihood of peripheral arterial disease among American adults
    Mohsen Mazidi, Dimitri P. Mikhailidis, Maciej Banach
    Journal of Diabetes and its Complications.2018; 32(6): 565.     CrossRef
  • Nutrition and Cardio-Metabolic Risk Factors: 20 Years of the Tehran Lipid and Glucose Study Findings
    Firoozeh Hosseini-Esfahani, Somaye Hosseinipour, Golaleh Asghari, Zahra Bahadoran, Nazanin Moslehi, Mahdieh Golzarand, Hanieh Ejtahed, Parvin Mirmiran, Fereidoun Azizi
    International Journal of Endocrinology and Metabolism.2018;[Epub]     CrossRef
  • Higher dietary acid load is weakly associated with higher adiposity measures and blood pressure in Japanese adults: The National Health and Nutrition Survey
    Kentaro Murakami, M. Barbara E. Livingstone, Hitomi Okubo, Satoshi Sasaki
    Nutrition Research.2017; 44: 67.     CrossRef
  • Accuracy and precision of estimation equations to predict net endogenous acid excretion using the Australian food database
    Benjamin H. Parmenter, Gary J. Slater, Lynda A. Frassetto
    Nutrition & Dietetics.2017; 74(3): 308.     CrossRef
  • Dietary acid load and mortality among Japanese men and women: the Japan Public Health Center–based Prospective Study
    Shamima Akter, Akiko Nanri, Tetsuya Mizoue, Mitsuhiko Noda, Norie Sawada, Shizuka Sasazuki, Shoichiro Tsugane
    The American Journal of Clinical Nutrition.2017; 106(1): 146.     CrossRef
  • Association between Dietary Acid Load and Insulin Resistance: Tehran Lipid and Glucose Study
    Sajjad Khalili Moghadam, Zahra Bahadoran, Parvin Mirmiran, Maryam Tohidi, Fereidoun Azizi
    Preventive Nutrition and Food Science.2016; 21(2): 104.     CrossRef
Close layer
Obesity and Metabolism
Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients
Zahra Bahadoran, Parvin Mirmiran, Maryam Zarif-yeaganeh, Homayoun Zojaji, Fereidoun Azizi
Endocrinol Metab. 2015;30(3):280-287.   Published online May 18, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.3.280
  • 4,777 View
  • 38 Download
  • 6 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   
Background

Helicobacter pylori infection and subsequent gastric inflammation have been proposed as risk factors for the development of insulin resistance and cardiovascular disease. In this study we assessed the possible association of H. pylori bacterial load, and serum biomarker of gastric inflammation with cardiometabolic risk factors in diabetic patients.

Methods

In this cross-sectional study, 84 H. pylori-infected type 2 diabetic patients were assessed for anthropometrics, biochemical and clinical measurements. Pearson correlation test, linear, and logarithmic regression curve estimation models were used to assess the association of H. pylori stool antigen (HpSAg) levels, and pepsinogen I (PGI) to pepsinogen II (PGII) ratio with fasting serum glucose, insulin, serum lipid and lipoprotein parameters, malondialdehyde, high-sensitive C-reactive protein (hs-CRP), systolic and diastolic blood pressure, body weight, waist circumference and lipid accumulation product (LAP) index.

Results

The mean age of participants was 54±10 years, and 44% were men. Mean HpSAg levels and PGI/PGII ratio were 0.24±0.23 µg/mL and 9.9±9.0, respectively. Higher HpSAg as well as lower PGI/PGII was correlated with higher anthropometric measures and LAP. A significant negative correlation between PGI/PGII ratio and blood pressure (r=-0.21 and r=-0.22, systolic and diastolic, respectively, P<0.05), serum insulin (r=-0.17, P=0.05), and hs-CRP (r=-0.17, P=0.05) was observed. A significant linear association between PGI/PGII ratio with serum triglycerides (β=-0.24, P<0.05), serum high density lipoprotein cholesterol (HDL-C; β=0.43, P<0.01), and triglycerides/HDL-C ratio (β=-0.28, P<0.05) were observed.

Conclusion

Higher H. pylori bacterial load and lower PGI/PGII ratio was associated with higher levels of cardiometabolic risk factors in H. pylori infected type 2 diabetic patients.

Citations

Citations to this article as recorded by  
  • Cardiovascular and Neurological Diseases and Association with Helicobacter Pylori Infection—An Overview
    Vlad Pădureanu, Dalia Dop, Daniel Cosmin Caragea, Dumitru Rădulescu, Rodica Pădureanu, Mircea-Cătălin Forțofoiu
    Diagnostics.2024; 14(16): 1781.     CrossRef
  • Both diet and Helicobacter pylori infection contribute to atherosclerosis in pre- and postmenopausal cynomolgus monkeys
    Traci L. Testerman, Cristina Semino-Mora, Jennifer A. Cann, Beidi Qiang, Edsel A. Peña, Hui Liu, Cara H. Olsen, Haiying Chen, Susan E. Appt, Jay R. Kaplan, Thomas C. Register, D. Scott Merrell, Andre Dubois, Xianwu Cheng
    PLOS ONE.2019; 14(9): e0222001.     CrossRef
  • Associations of Helicobacter pylori infection and peptic disease with diabetic mellitus: Results from a large population-based study
    Saeda Haj, Gabriel Chodick, Rotem Refaeli, Sophy Goren, Varda Shalev, Khitam Muhsen, David M. Ojcius
    PLOS ONE.2017; 12(8): e0183687.     CrossRef
  • Helicobacter Pylori Infection Is Associated with Dyslipidemia and Increased Levels of Oxidized LDL in Type-2 Diabetes Mellitus
    Mohamed Hasan Mukhtar, Wesam Ahmed Nasif, Abdullatif Taha Babakr
    Journal of Diabetes Mellitus.2016; 06(03): 185.     CrossRef
  • Update on prevention and treatment of Helicobacter pylori infection
    Zhao-Chun Chi
    World Chinese Journal of Digestology.2016; 24(16): 2454.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP